Wednesday, December 31, 2008

Lung Cancer: Still the Biggest Cancer Killer, by Far

(HealthDay News) — It’s the leading cause of cancer death in the United States, killing more people each year than breast, prostate, colon, liver, kidney and melanoma cancers combined.
It’s typically discovered too late to be treated successfully, with about 85 percent of victims dead within five years of diagnosis. Read More

Sunday, December 28, 2008

Thus Brehmers discovery was scientifically certified and in the medical professional world recognition.

Thus Brehmers discovery was scientifically certified and in the medical professional world recognition. The exciters go through a specific cycle, as the training medicine and bacteriology accept it with malaria as natural. The training medicine until today recognizes the development stages of viruses, bacteria and mushroom forms however not on. Although there is nevertheless no exception of the law of the eternal change and the unit of the macrocosm with the microcosmic (e.g. Qualquappe' Frog, Raupe' Butterfly) in whole nature. Read more

Thursday, December 25, 2008

Food gets cooked regardless of who manufactured the frying pan

Food gets cooked regardless of who manufactured the frying pan. Point being, FIR technology was used to produce the results.Are any of these studies directly related to the devices used in saunas or do they use other forms of infrared devices? The studies are about FIR technology. If the sauna incorporates FIR technology, then yes the technology is related.What's the difference between an actual heater and infrared heater in a sauna (in other words take out the infrared part)? "FIR Expands capillaries, which stimulates increased blood flow, regeneration, circulation and oxygenation. Read more

Body Cleanse Starter Kit

Monday, December 22, 2008

Low Doses of Melamine Won't Harm Kids' Kidneys

(HealthDay News) -- Low doses of melamine did not cause severe kidney problems in children exposed to the industrial chemical during the recent tainted milk scandal in China, Hong Kong researchers report.

The study is one of the first to measure the health impact of exposure to low doses of melamine, which was added to infant formula and other foods in mainland China to boost their protein content and help them pass muster on food-quality tests. Contaminated products were also sold in Hong Kong, but the researchers noted that those products contained much lower concentrations of melamine than the tainted products sold in mainland China.

Since early September, melamine-contaminated baby formula has sickened more than 54,000 children in China and is being blamed for at least four deaths. This latest finding suggests that the chances of the severe problems that occurred in China happening elsewhere are slim.

The chemical has turned up in dairy products sold across Asia and, to a lesser extent, in Europe and the United States. It has been detected in candies, chocolates and coffee drinks. Authorities in California and Connecticut found melamine in White Rabbit candies imported from China. There have been no reports of illness from contaminated Chinese milk products in the United States, health officials have said.

Last October, U.S. health officials said no amount of melamine is safe in infant formula. For all other foods, only amounts less than 2.5 parts per million are risk-free, U.S. Food and Drug Administration officials said at the time.

In the Hong Kong study, reported in this week's issue of BMJ, researchers from the Chinese University of Hong Kong examined slightly more than 3,000 children aged 12 or younger. All of them had consumed melamine-tainted products for a month or more. Every child was given a urine test, and an ultrasound was performed on their kidneys. Only one child had a kidney stone, and seven had possible melamine-related deposits in their kidneys. An additional 208 tested positive for blood in their urine, a possible sign of kidney troubles.

More information
To learn more, visit the U.S. Food and Drug Administration.

Friday, December 19, 2008

Bat Saliva-Based Stroke Drug Disappoints in Trial

(HealthDay News) -- An experimental clot-busting drug derived from the saliva of the vampire bat has failed to reduce stroke damage in a major trial.

But hope for the drug, called desmoteplase, remains alive, experts say, because the study may not have been large enough to provide clear results.

"The sample size was underpowered to detect any benefit," said study co-author Dr. Anthony J. Furlan, chairman of neurology at Case Western Reserve University, in Cleveland. "The simplest answer is that stroke is an extremely heterogeneous condition, and it is difficult to predict what the outcomes will be from a smaller size population."

Two earlier and smaller studies showed a benefit when desmoteplase was given intravenously to reopen brain arteries blocked by clots. But there was no significant difference in outcome in the latest trial, called DIAS-2, between stroke victims given desmoteplase and those who got a placebo, said a report to be published online on Dec. 17 in The Lancet Neurology.

But there remains vigorous debate about the best method to use in selecting those stroke patients who will be treated in the next trial, which is in the planning stage, Furlan added.

Desmoteplase was originally spotted in the saliva of the vampire bat, which uses the chemical to keep its victims' blood flowing freely, so it can suck a full meal.

The drug is contending to replace tissue plasminogen activator (tPA), the only current treatment for ischemic strokes, which are caused by blockage of a blood vessel. Most strokes are ischemic strokes; tPA is given by intravenous injection and works quickly to dissolve clots.

"But tPA must be given within three hours of a stroke, so only a small percentage of patients can get the treatment," Furlan noted. "We hope to triple that window to nine hours with desmoteplase."

But the strategy didn't work in DIAS-2, which included 186 people with strokes. A total of 123 patients received either a high or low dose of desmoteplase, while 63 got a placebo.

The death rate was actually higher for those who got the drug -- 11 percent in the low-dose group and 21 percent in the high-dose group, compared to 6 percent for those given a placebo.

So it's back to the drawing board, the researchers said, and one big question is whether the high-tech methods used to select participants in the trial were too sophisticated to be reliable.

DIAS-2 neurologists used either computerized tomography or magnetic resonance scanning to detect what they formally called "mismatches" -- brain areas that have been affected by the stroke but are not yet dead.

"There is a core area of tissue that is dead," Furlan explained. "Around that area are brain cells that are not yet dead, so they can be saved."

That is the theory, anyway. But it's a theory that some of the neurologists involved with the new drug are questioning.

"The current mismatch model is insufficient to identify those patients who would benefit," Furlan said. "We need a more sophisticated mismatch model."

But another school of thought among neurologists is that a simpler, rather than more complex, method of choosing trial participants might be better.

"There is some controversy about the design of the next trial," Furlan said. "Maybe we can select patients simply by determining whether a major artery is blocked, instead of the mismatch. The main way patients would be enrolled is by looking to see if a major artery is blocked out to nine hours, rather than for mismatch."

No firm start date has been set for DIAS-3, said Furlan, who is on the safety committee for the proposed trial.





The trial was funded by German drug company PAION Deutschland GmbH and U.S.-based Forest Laboratories, which had been working together to develop desmoteplase.

More information
Ischemic stroke and is treatment are explained by the U.S. Library of Medicine.

Tuesday, December 16, 2008

Complementary and Alternative Medicine for Children

Complementary and Alternative Medicine for Children - Complementary and alternative medicine (CAM) is a group of diverse medical and health care systems, practices, and products that are not presently considered to be part of c...... Read more


Saturday, December 13, 2008

introduction to the O3 congress may 2003

slide show presentation introducing medical ozone and it's known properties.
download pdf (size 632k)


6-Day Colon Cleanse Kit

6-Day Colon Cleanse Kit

$92.85
[ learn more ]

Add to Cart

Kit Includes: One bottle of Oxy-Powder®, one bottle of Latero-Flora™ and one bottle of Organic Aloe Vera Juice.



Cleanses: One 6-Day Advanced Oxygen Colon Cleanse (Oxy-Powder®). Takes 6 days to complete cleanse.



Dr. Group's Opinion: Optimal and complete cleansing in 6 days. Highly recommended for anyone.

Wednesday, December 10, 2008

See the most important element of your body come alive - your blood

See the most important element of your body come alive - your blood. You can actually watch as your blood reveals nutritional deficiencies, hormonal imbalances, digestive problems, liver stress, bacteria and parasite levels. Then discover how you cart be an active participant in correcting any areas of concern. Together, we will establish a proactive nutritional plan that will put you back in control of your own health. Read more

Slimirex 468x60 9 supplements

Sunday, December 7, 2008

More specifically, it measures the acid/base balance

More specifically, it measures the acid/base balance, the degree of oxidative stress (how well your body is breaking down foods, and how much your body Is being affected by toxins), and the concentration of minerals in your three body fluids. The blood measurements are good indicators of cell function all over the body. The saliva measurements reflect liver function very well, since most of the saliva is lymph, and most lymph is produced in the liver. Finally, the urine measurements reflect how well the kidneys are functioning. The kidneys filter the blood, so whatever Is In the first morning urine represents what the body has too much of. Read more

ParaTrex 468x60 Animated - Fatigued

Wednesday, December 3, 2008

This simple test, Biological Terrain Assessment, or BTA 2000

This simple test, Biological Terrain Assessment, or BTA 2000, costs about $150 and analyzes small amounts of blood, urine, and saliva to provide data about the current state of the building blocks of the body - your enzymes, amino acids, molecules, cells, and electrons. When you know how the chemistry of your body Is functioning, you can make lifestyle adjustments that support improvements in health. What is exciting about this particular test is its ability to pick up prepathological changes in the body that predispose one to bacterial and viral infections, as well as many chronic diseases. Read more